FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1345157004: Physiological dependence on substance in therapeutic use (disorder)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Oct 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5390395016 Physiological dependence on substance in therapeutic use en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5390396015 Physiological dependence on substance in therapeutic use (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

6 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Physiological dependence on substance in therapeutic use Is a Drug therapy finding true Inferred relationship Some
Physiological dependence on substance in therapeutic use Is a Disease true Inferred relationship Some
Physiological dependence on substance in therapeutic use Causative agent (attribute) A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. true Inferred relationship Some 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Dependence on steroid hormone in therapeutic use Is a True Physiological dependence on substance in therapeutic use Inferred relationship Some
Dependence on corticosteroid in therapeutic use (disorder) Is a True Physiological dependence on substance in therapeutic use Inferred relationship Some
Ergotamine dependence (disorder) Is a True Physiological dependence on substance in therapeutic use Inferred relationship Some
A condition where a patient requires continuous administration of the drug ruxolitinib to manage their symptoms or disease effectively. This dependence can develop because stopping or reducing the dose of ruxolitinib may lead to a relapse or worsening of the condition it was treating, such as myelofibrosis or polycythemia vera. Is a True Physiological dependence on substance in therapeutic use Inferred relationship Some
Selective serotonin re-uptake inhibitor dependence Is a True Physiological dependence on substance in therapeutic use Inferred relationship Some

Reference Sets

GB English

US English

Back to Start